New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

Los Angeles-based cancer researcher Flavia Pichiorri highlights the urgent need to strengthen the bridge between laboratory discovery and patient care in blood cancer research. LOS ANGELES, CA / ...

KARACHI: Several essential medicines including advanced immunotherapy drugs used in cancer treatment, vaccines ...

BLM’s ‘Notice of Intent’ Oregon’s forests and protected wildlife urgently need our rapid response to the BLM’s “Notice of Intent” released on Feb. 19. Essentially, the plan is to log approximately ...

Average payments could range between $6,000 to $165,000 - or more.

Key TakeawaysA highly sensitive DNA test can detect hidden leukemia cells that predict if a patient’s cancer is likely to returnPatients with the NPM1 mutation before a transplant were three to four ...

Fred Hutch Cancer Center medical oncologist Dr. Lisa Tachiki has been named a 2025 Cancer Research Fellow by the Kuni Foundation, an honor that includes an unrestricted, two-year $300,000 award.

In the fall of 2022, when I was 42 and living with my wife and three young kids in a small town in northwest Minnesota, a specialist at an unfamiliar hospital approached us with some test results. He ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

In a community known for stepping up when neighbors are in need, Hatteras Island residents have come together in the past several weeks to support five-year-old Milly King and her […] ...